Metropolitan Veterinary Hospital
At Metropolitan Veterinary Hospital, we are dedicated to advancing veterinary medicine through our active involvement in clinical research. By participating in innovative studies, we help shape the future of animal health, enhance patient outcomes, and fulfill our mission of providing the highest quality veterinary care.
Our veterinarians frequently engage in clinical studies across various disciplines. Participating in these clinical studies offers numerous benefits. Veterinarians gain access to new techniques, treatments, and knowledge, while pets live longer, healthier lives through improved care.
Continue reading to learn more about the current Clinical Trials offered at Metropolitan Veterinary Hospital.
Current Clinical Trials
Critical Care
Aims to understand the role of DNA fragments called nucleosomes in dogs with sepsis and trauma.
(Cleveland)
Cardiology
Fully funded placebo-controlled study evaluating the effectiveness of a novel medication in managing left ventricular hypertrophy associated with subclinical HCM in cats.
(Akron)
CARE Study (Akron)
This study is evaluating an investigational medication for the treatment of feline heart failure.
Internal Medicine
Check back for trials coming soon!
Neurology
Check back for trials coming soon!
Oncology
Precision Medicine Umbrella Study for Hemangiosarcoma (PUSH) (Akron)
Two-phase study. Phase two is fully funded oncologic care. This study seeks to develop a cure for dogs with hemangiosarcoma through a combination of molecular analysis and novel therapeutics.
Volition Feline LSA Study (Akron & Cleveland)
Uses a new diagnostic tool to explore levels of DNA fragments in the blood of cats with lymphoma to potentially improve early detections and treatment.
Canine Oral Melanoma Study (Cleveland)
Fully funded study of novel immunotherapy for dogs with stage 3 oral melanoma.
Oncologic Sample Collection Study (Akron & Cleveland)
This study aims to improve cancer diagnostics by providing crucial samples to IDEXX Laboratory.
Stratification of Outcomes for Lymphoma In Dogs (SOLID) – NEW STUDY (Both locations)
This fully funded clinical trial seeks to refine the canine lymphoma prognosis further and inform treatment decisions. This study also offers a substantial fiscal incentive for our clients!
Autologous Cancer Vaccine with Checkpoint Inhibitor for Treatment of Canine Osteosarcoma (Akron & Cleveland)
The study is evaluating a personalized cancer vaccine (K9-ACV) combined with a checkpoint inhibitor, both designed to work with your dog’s immune system to fight cancer—potentially offering an alternative to chemotherapy. Qualifying candidates receive an incentive of $4,000 towards surgery and fully funded oncologic care. For pet owners interested in this study, please click here for more information.
Canalevia Study (Akron)
The objective of the ongoing, prospective, randomized, open-label field study in dogs undergoing chemotherapy treatment across the U.S. is to collect real-world data to demonstrate real-world evidence of the clinical effectiveness for Canalevia-CA1 for the treatment of CID in dogs to support potential full FDA approval of the drug for this indication.
Ophthalmology
Check back for trials coming soon!
Surgery
Check back for trials coming soon!
Avian & Exotics
Check back for trials coming soon!
